M GP2 (Glipizide extended-release 2.5 mg)

Pill imprint M GP2 has been identified as Glipizide extended-release 2.5 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide extended-release

Imprint:

M GP2

Strength:

2.5 mg

Color:

Blue

Shape:

Round

Availability:

Prescription only

Drug Class:

Sulfonylureas

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.